ECONOMY AFFAIRS AUGUST 2009
- Following are the highlights of the new Foreign Trade Policy that was unveiled by Commerce Minister Anand Sharma
- Duty entitlement passbook scheme extended till December 2010
- Extension of sops for export-oriented units till March 2011
- Export target of $200 billion set for 2010-11
- Growth target of 15 per cent for next two years, 25 per cent thereafter
- Inter-ministerial group to address issues raised by exporters
- Obligation under export promotion capital goods scheme relaxed
- Permission for tax refund scheme for jewellery sector
- No fee on grant of incentives to cut transaction costs
- Steps to help exporters reduce transaction costs
- Plan for diamond bourses in the country
- Single-window scheme for farm exports
- Re-export of unused leather allowed subject to 50 per cent duty
- Minimum value addition for tea reduced to 50 per cent from 100 per cent
- Export units allowed to sell 90 per cent of goods in domestic market
- Provision for state-run banks to provide dollar credits
- Twenty-six new markets added to focus market scheme
- Sops under focus market scheme hiked from 2.5 per cent to 3 per cent
- Number of duty-free samples for exporters raised to 50 pieces from 15
- New directorate of trade remedy measures to be set up
- Zero duty under technology upgrade scheme
- Reader’s Digest Association Inc., owned by the New York private equity firm Ripplewood Holdings decided to file for bankruptcy protection.
- New Income Tax Slab under New Direct Tax Code 2009Income Tax Slab Under New Direct Tax Code 2009 applicable for A.Y. 2011-12Individual MaleUp to Rs. 1,60,000NILRs.1,60,001 – Rs.10,00,00010%Rs.10,00,001 -Rs. 25,00,00020%Above Rs. 25,00,00130%Individual FemaleUp to Rs. 1,90,000NILRs.1,90,001 – Rs.10,00,00010%Rs.10,00,001 -Rs. 25,00,00020%Above Rs. 25,00,00130%Individual Senior CitizensUp to Rs. 2,40,000NILRs.2,40,001 to Rs. 10,00,00010%Rs.10,00,001 to Rs. 25,00,00020%Above Rs. 25,00,00130%
- Aurobindo Pharma to buy Trident Life Sciences.It would acquire 100% stake of Trident Life Sciences subject to suitable agreements between the parties.
No comments:
Post a Comment